nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—NR3C1—type 2 diabetes mellitus	0.303	0.633	CbGaD
Budesonide—CYP3A4—type 2 diabetes mellitus	0.176	0.367	CbGaD
Budesonide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.044	0.152	CbGbCtD
Budesonide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0392	0.136	CbGbCtD
Budesonide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0358	0.124	CbGbCtD
Budesonide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0313	0.109	CbGbCtD
Budesonide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0283	0.0982	CbGbCtD
Budesonide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0215	0.0744	CbGbCtD
Budesonide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0206	0.0713	CbGbCtD
Budesonide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0206	0.0713	CbGbCtD
Budesonide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0195	0.0675	CbGbCtD
Budesonide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0145	0.0503	CbGbCtD
Budesonide—CYP3A4—Losartan—type 2 diabetes mellitus	0.0133	0.046	CbGbCtD
Budesonide—Prednisone—HSD11B1—type 2 diabetes mellitus	0.000627	0.118	CrCbGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IRS2—type 2 diabetes mellitus	0.000365	0.00859	CbGpPWpGaD
Budesonide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—type 2 diabetes mellitus	0.000359	0.00845	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—type 2 diabetes mellitus	0.000357	0.0084	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—RETN—type 2 diabetes mellitus	0.000354	0.00833	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYB5R4—type 2 diabetes mellitus	0.000348	0.00818	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—CPT1A—type 2 diabetes mellitus	0.000345	0.0081	CbGpPWpGaD
Budesonide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—type 2 diabetes mellitus	0.000343	0.00806	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—NAMPT—type 2 diabetes mellitus	0.000338	0.00794	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptors—AR—type 2 diabetes mellitus	0.000321	0.00755	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—F7—type 2 diabetes mellitus	0.00032	0.00753	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IRS1—type 2 diabetes mellitus	0.000319	0.0075	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—type 2 diabetes mellitus	0.000311	0.00732	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—AANAT—type 2 diabetes mellitus	0.000311	0.0073	CbGpPWpGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—type 2 diabetes mellitus	0.000309	0.00726	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.000306	0.0072	CbGpPWpGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—type 2 diabetes mellitus	0.000305	0.00717	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—SREBF1—type 2 diabetes mellitus	0.000301	0.00708	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—ATF3—type 2 diabetes mellitus	0.000294	0.00691	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.000285	0.0067	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.000285	0.0067	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—HNF1A—type 2 diabetes mellitus	0.00028	0.00659	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—type 2 diabetes mellitus	0.000262	0.00615	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—MIF—type 2 diabetes mellitus	0.000259	0.00608	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA6—type 2 diabetes mellitus	0.000258	0.00607	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—AR—type 2 diabetes mellitus	0.000254	0.00596	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—type 2 diabetes mellitus	0.000253	0.00594	CbGpPWpGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—type 2 diabetes mellitus	0.000249	0.00584	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—AR—type 2 diabetes mellitus	0.000246	0.00578	CbGpPWpGaD
Budesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—type 2 diabetes mellitus	0.000245	0.00575	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptors—PPARA—type 2 diabetes mellitus	0.000243	0.00572	CbGpPWpGaD
Budesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—type 2 diabetes mellitus	0.000242	0.00569	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—TIMP1—type 2 diabetes mellitus	0.000235	0.00553	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—PCK1—type 2 diabetes mellitus	0.000235	0.00552	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—PPARGC1A—type 2 diabetes mellitus	0.000225	0.00529	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—type 2 diabetes mellitus	0.000224	0.00527	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—AVP—type 2 diabetes mellitus	0.000222	0.00522	CbGpPWpGaD
Budesonide—CYP3A4—Estrogen metabolism—CYP1A2—type 2 diabetes mellitus	0.00022	0.00518	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—TCF7L2—type 2 diabetes mellitus	0.000219	0.00515	CbGpPWpGaD
Budesonide—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—type 2 diabetes mellitus	0.000211	0.00496	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—type 2 diabetes mellitus	0.000207	0.00486	CbGpPWpGaD
Budesonide—CYP3A4—Xenobiotics—CYP2E1—type 2 diabetes mellitus	0.000205	0.00481	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—type 2 diabetes mellitus	0.000203	0.00477	CbGpPWpGaD
Budesonide—CYP3A4—Xenobiotics—CYP1A2—type 2 diabetes mellitus	0.000202	0.00476	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptors—PPARG—type 2 diabetes mellitus	0.000201	0.00473	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—GJA1—type 2 diabetes mellitus	0.000198	0.00467	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—type 2 diabetes mellitus	0.000197	0.00463	CbGpPWpGaD
Budesonide—CYP3A4—Tamoxifen metabolism—CYP2E1—type 2 diabetes mellitus	0.000197	0.00463	CbGpPWpGaD
Budesonide—CYP3A4—Tamoxifen metabolism—CYP1A2—type 2 diabetes mellitus	0.000195	0.00458	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—PPARA—type 2 diabetes mellitus	0.000192	0.00452	CbGpPWpGaD
Budesonide—Clocortolone—NR3C1—type 2 diabetes mellitus	0.000187	0.0353	CrCbGaD
Budesonide—Prednicarbate—NR3C1—type 2 diabetes mellitus	0.000187	0.0353	CrCbGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—type 2 diabetes mellitus	0.000185	0.00435	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—PPARA—type 2 diabetes mellitus	0.000181	0.00425	CbGpPWpGaD
Budesonide—Diflorasone—NR3C1—type 2 diabetes mellitus	0.000177	0.0334	CrCbGaD
Budesonide—Desonide—NR3C1—type 2 diabetes mellitus	0.000177	0.0334	CrCbGaD
Budesonide—NR3C1—Circadian Clock—HIF1A—type 2 diabetes mellitus	0.000176	0.00414	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—type 2 diabetes mellitus	0.000175	0.00412	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—type 2 diabetes mellitus	0.000175	0.00412	CbGpPWpGaD
Budesonide—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—type 2 diabetes mellitus	0.000174	0.0041	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—EDN1—type 2 diabetes mellitus	0.000174	0.00409	CbGpPWpGaD
Budesonide—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.000173	0.0326	CrCbGaD
Budesonide—Loteprednol—NR3C1—type 2 diabetes mellitus	0.000171	0.0322	CrCbGaD
Budesonide—NR3C1—Adipogenesis—NAMPT—type 2 diabetes mellitus	0.00017	0.00399	CbGpPWpGaD
Budesonide—CYP3A4—Estrogen metabolism—GSTM1—type 2 diabetes mellitus	0.000169	0.00397	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—type 2 diabetes mellitus	0.000165	0.00389	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—type 2 diabetes mellitus	0.000161	0.0038	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—type 2 diabetes mellitus	0.000161	0.00378	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—type 2 diabetes mellitus	0.000159	0.00374	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—HMGA1—type 2 diabetes mellitus	0.000154	0.00363	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—SREBF1—type 2 diabetes mellitus	0.000151	0.00356	CbGpPWpGaD
Budesonide—Flurandrenolide—NR3C1—type 2 diabetes mellitus	0.000151	0.0285	CrCbGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.00015	0.00352	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MMP1—type 2 diabetes mellitus	0.000146	0.00344	CbGpPWpGaD
Budesonide—Hydrocortamate—NR3C1—type 2 diabetes mellitus	0.000146	0.0276	CrCbGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000146	0.00343	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—HIF1A—type 2 diabetes mellitus	0.000145	0.00341	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—AGT—type 2 diabetes mellitus	0.000145	0.0034	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—ADIPOQ—type 2 diabetes mellitus	0.000139	0.00327	CbGpPWpGaD
Budesonide—Amcinonide—NR3C1—type 2 diabetes mellitus	0.000136	0.0256	CrCbGaD
Budesonide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—type 2 diabetes mellitus	0.000136	0.0032	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—SERPINE1—type 2 diabetes mellitus	0.000135	0.00317	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	0.000134	0.00315	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—type 2 diabetes mellitus	0.000133	0.00314	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—type 2 diabetes mellitus	0.000132	0.00311	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—SLC2A4—type 2 diabetes mellitus	0.000131	0.00308	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000131	0.00307	CbGpPWpGaD
Budesonide—Mometasone—NR3C1—type 2 diabetes mellitus	0.000129	0.0244	CrCbGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—type 2 diabetes mellitus	0.000129	0.00303	CbGpPWpGaD
Budesonide—Rimexolone—NR3C1—type 2 diabetes mellitus	0.000128	0.0241	CrCbGaD
Budesonide—Fluocinonide—NR3C1—type 2 diabetes mellitus	0.000121	0.0227	CrCbGaD
Budesonide—Beclomethasone—NR3C1—type 2 diabetes mellitus	0.000121	0.0227	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—CCL2—type 2 diabetes mellitus	0.000119	0.0028	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000119	0.00279	CbGpPWpGaD
Budesonide—Alclometasone—NR3C1—type 2 diabetes mellitus	0.000117	0.0221	CrCbGaD
Budesonide—Fluocinolone Acetonide—NR3C1—type 2 diabetes mellitus	0.000117	0.0221	CrCbGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—type 2 diabetes mellitus	0.000117	0.00275	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	0.000115	0.0027	CbGpPWpGaD
Budesonide—Flunisolide—NR3C1—type 2 diabetes mellitus	0.000114	0.0215	CrCbGaD
Budesonide—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	0.000114	0.0215	CrCbGaD
Budesonide—NR3C1—Adipogenesis—PPARGC1A—type 2 diabetes mellitus	0.000113	0.00266	CbGpPWpGaD
Budesonide—Paramethasone—NR3C1—type 2 diabetes mellitus	0.000113	0.0212	CrCbGaD
Budesonide—Ciclesonide—NR3C1—type 2 diabetes mellitus	0.000111	0.0209	CrCbGaD
Budesonide—Fluorometholone—NR3C1—type 2 diabetes mellitus	0.00011	0.0207	CrCbGaD
Budesonide—Methylprednisolone—NR3C1—type 2 diabetes mellitus	0.000106	0.02	CrCbGaD
Budesonide—CYP3A4—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	0.000105	0.00247	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000105	0.00246	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	0.000104	0.00244	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000104	0.00244	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000104	0.00244	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	0.000103	0.00242	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—LPL—type 2 diabetes mellitus	0.000103	0.00242	CbGpPWpGaD
Budesonide—Dexamethasone—CYP11A1—type 2 diabetes mellitus	0.000102	0.0192	CrCbGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	0.000102	0.00239	CbGpPWpGaD
Budesonide—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	9.99e-05	0.0188	CrCbGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	9.89e-05	0.00232	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	9.8e-05	0.0023	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	9.77e-05	0.0023	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	9.77e-05	0.0023	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	9.64e-05	0.00227	CbGpPWpGaD
Budesonide—Hydrocortisone—SHBG—type 2 diabetes mellitus	9.64e-05	0.0182	CrCbGaD
Budesonide—NR3C1—Adipogenesis—FAS—type 2 diabetes mellitus	9.4e-05	0.00221	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	9.28e-05	0.00218	CbGpPWpGaD
Budesonide—Angioedema—Losartan—type 2 diabetes mellitus	9.14e-05	0.000493	CcSEcCtD
Budesonide—Infection—Metformin—type 2 diabetes mellitus	9.13e-05	0.000493	CcSEcCtD
Budesonide—Insomnia—Valsartan—type 2 diabetes mellitus	9.13e-05	0.000492	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—PPARA—type 2 diabetes mellitus	9.09e-05	0.00214	CbGpPWpGaD
Budesonide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.09e-05	0.00049	CcSEcCtD
Budesonide—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.06e-05	0.000489	CcSEcCtD
Budesonide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.05e-05	0.000488	CcSEcCtD
Budesonide—Chest pain—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.000488	CcSEcCtD
Budesonide—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.000488	CcSEcCtD
Budesonide—Myalgia—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.000488	CcSEcCtD
Budesonide—Shock—Metformin—type 2 diabetes mellitus	9.04e-05	0.000488	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—MAT1A—type 2 diabetes mellitus	9.03e-05	0.00212	CbGpPWpGaD
Budesonide—Insomnia—Orlistat—type 2 diabetes mellitus	9.02e-05	0.000487	CcSEcCtD
Budesonide—Malaise—Losartan—type 2 diabetes mellitus	9.02e-05	0.000487	CcSEcCtD
Budesonide—Anxiety—Irbesartan—type 2 diabetes mellitus	9.02e-05	0.000486	CcSEcCtD
Budesonide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.01e-05	0.000486	CcSEcCtD
Budesonide—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.01e-05	0.000486	CcSEcCtD
Budesonide—Dyspnoea—Valsartan—type 2 diabetes mellitus	9e-05	0.000485	CcSEcCtD
Budesonide—Vertigo—Losartan—type 2 diabetes mellitus	8.99e-05	0.000485	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	8.98e-05	0.000485	CcSEcCtD
Budesonide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	8.98e-05	0.000485	CcSEcCtD
Budesonide—Somnolence—Valsartan—type 2 diabetes mellitus	8.97e-05	0.000484	CcSEcCtD
Budesonide—Syncope—Losartan—type 2 diabetes mellitus	8.97e-05	0.000484	CcSEcCtD
Budesonide—Triamcinolone—NR3C1—type 2 diabetes mellitus	8.97e-05	0.0169	CrCbGaD
Budesonide—Paraesthesia—Orlistat—type 2 diabetes mellitus	8.95e-05	0.000483	CcSEcCtD
Budesonide—Discomfort—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.000482	CcSEcCtD
Budesonide—Skin disorder—Metformin—type 2 diabetes mellitus	8.93e-05	0.000482	CcSEcCtD
Budesonide—Immune system disorder—Ramipril—type 2 diabetes mellitus	8.9e-05	0.00048	CcSEcCtD
Budesonide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	8.88e-05	0.000479	CcSEcCtD
Budesonide—Dyspepsia—Valsartan—type 2 diabetes mellitus	8.88e-05	0.000479	CcSEcCtD
Budesonide—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	8.88e-05	0.000479	CcSEcCtD
Budesonide—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.85e-05	0.000477	CcSEcCtD
Budesonide—Dry mouth—Irbesartan—type 2 diabetes mellitus	8.85e-05	0.000477	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—HIF1A—type 2 diabetes mellitus	8.84e-05	0.00208	CbGpPWpGaD
Budesonide—Palpitations—Losartan—type 2 diabetes mellitus	8.84e-05	0.000477	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—IRS2—type 2 diabetes mellitus	8.82e-05	0.00207	CbGpPWpGaD
Budesonide—Nausea—Glimepiride—type 2 diabetes mellitus	8.81e-05	0.000475	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—AGT—type 2 diabetes mellitus	8.81e-05	0.00207	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	8.8e-05	0.00207	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—type 2 diabetes mellitus	8.8e-05	0.00207	CbGpPWpGaD
Budesonide—Loss of consciousness—Losartan—type 2 diabetes mellitus	8.79e-05	0.000474	CcSEcCtD
Budesonide—Nausea—Sitagliptin—type 2 diabetes mellitus	8.78e-05	0.000474	CcSEcCtD
Budesonide—Dyspepsia—Orlistat—type 2 diabetes mellitus	8.78e-05	0.000474	CcSEcCtD
Budesonide—Asthenia—Glyburide—type 2 diabetes mellitus	8.78e-05	0.000474	CcSEcCtD
Budesonide—Decreased appetite—Valsartan—type 2 diabetes mellitus	8.77e-05	0.000473	CcSEcCtD
Budesonide—Anorexia—Metformin—type 2 diabetes mellitus	8.76e-05	0.000473	CcSEcCtD
Budesonide—Cough—Losartan—type 2 diabetes mellitus	8.73e-05	0.000471	CcSEcCtD
Budesonide—Urticaria—Gliclazide—type 2 diabetes mellitus	8.73e-05	0.000471	CcSEcCtD
Budesonide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	8.71e-05	0.00047	CcSEcCtD
Budesonide—Alopecia—Ramipril—type 2 diabetes mellitus	8.7e-05	0.00047	CcSEcCtD
Budesonide—Fatigue—Valsartan—type 2 diabetes mellitus	8.7e-05	0.000469	CcSEcCtD
Budesonide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	8.68e-05	0.000468	CcSEcCtD
Budesonide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	8.68e-05	0.000468	CcSEcCtD
Budesonide—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	8.67e-05	0.000468	CcSEcCtD
Budesonide—Decreased appetite—Orlistat—type 2 diabetes mellitus	8.67e-05	0.000468	CcSEcCtD
Budesonide—Pruritus—Glyburide—type 2 diabetes mellitus	8.65e-05	0.000467	CcSEcCtD
Budesonide—Mental disorder—Ramipril—type 2 diabetes mellitus	8.63e-05	0.000466	CcSEcCtD
Budesonide—Constipation—Valsartan—type 2 diabetes mellitus	8.63e-05	0.000466	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—LEP—type 2 diabetes mellitus	8.63e-05	0.00203	CbGpPWpGaD
Budesonide—Infection—Irbesartan—type 2 diabetes mellitus	8.62e-05	0.000465	CcSEcCtD
Budesonide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	8.61e-05	0.000464	CcSEcCtD
Budesonide—Fatigue—Orlistat—type 2 diabetes mellitus	8.6e-05	0.000464	CcSEcCtD
Budesonide—Malnutrition—Ramipril—type 2 diabetes mellitus	8.58e-05	0.000463	CcSEcCtD
Budesonide—Shock—Irbesartan—type 2 diabetes mellitus	8.53e-05	0.00046	CcSEcCtD
Budesonide—Pain—Orlistat—type 2 diabetes mellitus	8.53e-05	0.00046	CcSEcCtD
Budesonide—Myalgia—Losartan—type 2 diabetes mellitus	8.51e-05	0.000459	CcSEcCtD
Budesonide—Chest pain—Losartan—type 2 diabetes mellitus	8.51e-05	0.000459	CcSEcCtD
Budesonide—Arthralgia—Losartan—type 2 diabetes mellitus	8.51e-05	0.000459	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—MMP9—type 2 diabetes mellitus	8.51e-05	0.002	CbGpPWpGaD
Budesonide—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.51e-05	0.000459	CcSEcCtD
Budesonide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.000459	CcSEcCtD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	8.5e-05	0.002	CbGpPWpGaD
Budesonide—Anxiety—Losartan—type 2 diabetes mellitus	8.48e-05	0.000458	CcSEcCtD
Budesonide—Hydrocortamate—CYP3A4—type 2 diabetes mellitus	8.48e-05	0.016	CrCbGaD
Budesonide—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.46e-05	0.000457	CcSEcCtD
Budesonide—Dexamethasone—NOS2—type 2 diabetes mellitus	8.45e-05	0.0159	CrCbGaD
Budesonide—CYP3A4—Tryptophan metabolism—CAT—type 2 diabetes mellitus	8.44e-05	0.00198	CbGpPWpGaD
Budesonide—Rash—Bromocriptine—type 2 diabetes mellitus	8.44e-05	0.000455	CcSEcCtD
Budesonide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.43e-05	0.000455	CcSEcCtD
Budesonide—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.42e-05	0.000455	CcSEcCtD
Budesonide—Tension—Ramipril—type 2 diabetes mellitus	8.41e-05	0.000454	CcSEcCtD
Budesonide—Discomfort—Losartan—type 2 diabetes mellitus	8.41e-05	0.000454	CcSEcCtD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	8.41e-05	0.00198	CbGpPWpGaD
Budesonide—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000453	CcSEcCtD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	8.39e-05	0.00197	CbGpPWpGaD
Budesonide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.38e-05	0.000452	CcSEcCtD
Budesonide—Headache—Bromocriptine—type 2 diabetes mellitus	8.38e-05	0.000452	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.37e-05	0.000452	CcSEcCtD
Budesonide—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.37e-05	0.000452	CcSEcCtD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	8.35e-05	0.00196	CbGpPWpGaD
Budesonide—Nervousness—Ramipril—type 2 diabetes mellitus	8.33e-05	0.000449	CcSEcCtD
Budesonide—Dry mouth—Losartan—type 2 diabetes mellitus	8.33e-05	0.000449	CcSEcCtD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	8.3e-05	0.00195	CbGpPWpGaD
Budesonide—Anorexia—Irbesartan—type 2 diabetes mellitus	8.27e-05	0.000446	CcSEcCtD
Budesonide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.25e-05	0.000445	CcSEcCtD
Budesonide—Paraesthesia—Metformin—type 2 diabetes mellitus	8.25e-05	0.000445	CcSEcCtD
Budesonide—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.24e-05	0.000445	CcSEcCtD
Budesonide—Confusional state—Losartan—type 2 diabetes mellitus	8.23e-05	0.000444	CcSEcCtD
Budesonide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.22e-05	0.000443	CcSEcCtD
Budesonide—Dyspnoea—Metformin—type 2 diabetes mellitus	8.19e-05	0.000442	CcSEcCtD
Budesonide—Somnolence—Metformin—type 2 diabetes mellitus	8.17e-05	0.000441	CcSEcCtD
Budesonide—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.16e-05	0.00044	CcSEcCtD
Budesonide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.15e-05	0.00044	CcSEcCtD
Budesonide—Prednisone—NR3C1—type 2 diabetes mellitus	8.13e-05	0.0153	CrCbGaD
Budesonide—Infection—Losartan—type 2 diabetes mellitus	8.11e-05	0.000437	CcSEcCtD
Budesonide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.09e-05	0.000437	CcSEcCtD
Budesonide—Dyspepsia—Metformin—type 2 diabetes mellitus	8.09e-05	0.000436	CcSEcCtD
Budesonide—Tremor—Ramipril—type 2 diabetes mellitus	8.03e-05	0.000433	CcSEcCtD
Budesonide—Shock—Losartan—type 2 diabetes mellitus	8.03e-05	0.000433	CcSEcCtD
Budesonide—Urticaria—Valsartan—type 2 diabetes mellitus	8.02e-05	0.000433	CcSEcCtD
Budesonide—Nervous system disorder—Losartan—type 2 diabetes mellitus	8e-05	0.000432	CcSEcCtD
Budesonide—Decreased appetite—Metformin—type 2 diabetes mellitus	7.99e-05	0.000431	CcSEcCtD
Budesonide—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.98e-05	0.00043	CcSEcCtD
Budesonide—Tachycardia—Losartan—type 2 diabetes mellitus	7.97e-05	0.00043	CcSEcCtD
Budesonide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	7.96e-05	0.000429	CcSEcCtD
Budesonide—Nausea—Bromocriptine—type 2 diabetes mellitus	7.95e-05	0.000429	CcSEcCtD
Budesonide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	7.93e-05	0.000428	CcSEcCtD
Budesonide—Fatigue—Metformin—type 2 diabetes mellitus	7.92e-05	0.000427	CcSEcCtD
Budesonide—Urticaria—Orlistat—type 2 diabetes mellitus	7.92e-05	0.000427	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.9e-05	0.000426	CcSEcCtD
Budesonide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.89e-05	0.000426	CcSEcCtD
Budesonide—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.88e-05	0.000425	CcSEcCtD
Budesonide—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.88e-05	0.000425	CcSEcCtD
Budesonide—Asthenia—Gliclazide—type 2 diabetes mellitus	7.88e-05	0.000425	CcSEcCtD
Budesonide—Agitation—Ramipril—type 2 diabetes mellitus	7.88e-05	0.000425	CcSEcCtD
Budesonide—Constipation—Metformin—type 2 diabetes mellitus	7.86e-05	0.000424	CcSEcCtD
Budesonide—Angioedema—Ramipril—type 2 diabetes mellitus	7.84e-05	0.000423	CcSEcCtD
Budesonide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7.79e-05	0.00042	CcSEcCtD
Budesonide—Anorexia—Losartan—type 2 diabetes mellitus	7.78e-05	0.00042	CcSEcCtD
Budesonide—Vomiting—Glyburide—type 2 diabetes mellitus	7.78e-05	0.00042	CcSEcCtD
Budesonide—Pruritus—Gliclazide—type 2 diabetes mellitus	7.77e-05	0.000419	CcSEcCtD
Budesonide—Malaise—Ramipril—type 2 diabetes mellitus	7.73e-05	0.000417	CcSEcCtD
Budesonide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.73e-05	0.000417	CcSEcCtD
Budesonide—Rash—Glyburide—type 2 diabetes mellitus	7.71e-05	0.000416	CcSEcCtD
Budesonide—Somnolence—Irbesartan—type 2 diabetes mellitus	7.71e-05	0.000416	CcSEcCtD
Budesonide—Dermatitis—Glyburide—type 2 diabetes mellitus	7.71e-05	0.000416	CcSEcCtD
Budesonide—Vertigo—Ramipril—type 2 diabetes mellitus	7.7e-05	0.000416	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—IRS1—type 2 diabetes mellitus	7.7e-05	0.00181	CbGpPWpGaD
Budesonide—Syncope—Ramipril—type 2 diabetes mellitus	7.69e-05	0.000415	CcSEcCtD
Budesonide—Headache—Glyburide—type 2 diabetes mellitus	7.66e-05	0.000413	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	7.64e-05	0.0018	CbGpPWpGaD
Budesonide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	7.63e-05	0.000412	CcSEcCtD
Budesonide—Palpitations—Ramipril—type 2 diabetes mellitus	7.58e-05	0.000409	CcSEcCtD
Budesonide—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.57e-05	0.000409	CcSEcCtD
Budesonide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.54e-05	0.000407	CcSEcCtD
Budesonide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000407	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—PPARG—type 2 diabetes mellitus	7.52e-05	0.00177	CbGpPWpGaD
Budesonide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.52e-05	0.000405	CcSEcCtD
Budesonide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.52e-05	0.000405	CcSEcCtD
Budesonide—Prednisolone—NR3C1—type 2 diabetes mellitus	7.5e-05	0.0141	CrCbGaD
Budesonide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.49e-05	0.000404	CcSEcCtD
Budesonide—Cough—Ramipril—type 2 diabetes mellitus	7.48e-05	0.000404	CcSEcCtD
Budesonide—Fatigue—Irbesartan—type 2 diabetes mellitus	7.48e-05	0.000403	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.44e-05	0.000401	CcSEcCtD
Budesonide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.44e-05	0.000401	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—type 2 diabetes mellitus	7.42e-05	0.00174	CbGpPWpGaD
Budesonide—Pain—Irbesartan—type 2 diabetes mellitus	7.42e-05	0.0004	CcSEcCtD
Budesonide—Constipation—Irbesartan—type 2 diabetes mellitus	7.42e-05	0.0004	CcSEcCtD
Budesonide—Insomnia—Losartan—type 2 diabetes mellitus	7.38e-05	0.000398	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—INS—type 2 diabetes mellitus	7.37e-05	0.00173	CbGpPWpGaD
Budesonide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.35e-05	0.000396	CcSEcCtD
Budesonide—Betamethasone—NR3C1—type 2 diabetes mellitus	7.34e-05	0.0138	CrCbGaD
Budesonide—Paraesthesia—Losartan—type 2 diabetes mellitus	7.33e-05	0.000395	CcSEcCtD
Budesonide—Urticaria—Metformin—type 2 diabetes mellitus	7.3e-05	0.000394	CcSEcCtD
Budesonide—Arthralgia—Ramipril—type 2 diabetes mellitus	7.3e-05	0.000394	CcSEcCtD
Budesonide—Chest pain—Ramipril—type 2 diabetes mellitus	7.3e-05	0.000394	CcSEcCtD
Budesonide—Myalgia—Ramipril—type 2 diabetes mellitus	7.3e-05	0.000394	CcSEcCtD
Budesonide—Dyspnoea—Losartan—type 2 diabetes mellitus	7.28e-05	0.000393	CcSEcCtD
Budesonide—Anxiety—Ramipril—type 2 diabetes mellitus	7.28e-05	0.000393	CcSEcCtD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	7.27e-05	0.00171	CbGpPWpGaD
Budesonide—Nausea—Glyburide—type 2 diabetes mellitus	7.27e-05	0.000392	CcSEcCtD
Budesonide—Abdominal pain—Metformin—type 2 diabetes mellitus	7.27e-05	0.000392	CcSEcCtD
Budesonide—Dizziness—Gliclazide—type 2 diabetes mellitus	7.26e-05	0.000392	CcSEcCtD
Budesonide—Somnolence—Losartan—type 2 diabetes mellitus	7.26e-05	0.000391	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000391	CcSEcCtD
Budesonide—Asthenia—Valsartan—type 2 diabetes mellitus	7.24e-05	0.000391	CcSEcCtD
Budesonide—Discomfort—Ramipril—type 2 diabetes mellitus	7.21e-05	0.000389	CcSEcCtD
Budesonide—Dyspepsia—Losartan—type 2 diabetes mellitus	7.18e-05	0.000388	CcSEcCtD
Budesonide—NR3C1—Endoderm Differentiation—TGFB1—type 2 diabetes mellitus	7.18e-05	0.00169	CbGpPWpGaD
Budesonide—Asthenia—Orlistat—type 2 diabetes mellitus	7.15e-05	0.000386	CcSEcCtD
Budesonide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.000386	CcSEcCtD
Budesonide—Pruritus—Valsartan—type 2 diabetes mellitus	7.14e-05	0.000385	CcSEcCtD
Budesonide—Dry mouth—Ramipril—type 2 diabetes mellitus	7.14e-05	0.000385	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—IGF1—type 2 diabetes mellitus	7.13e-05	0.00168	CbGpPWpGaD
Budesonide—Decreased appetite—Losartan—type 2 diabetes mellitus	7.1e-05	0.000383	CcSEcCtD
Budesonide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.09e-05	0.000383	CcSEcCtD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	7.07e-05	0.00166	CbGpPWpGaD
Budesonide—Confusional state—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000381	CcSEcCtD
Budesonide—Pruritus—Orlistat—type 2 diabetes mellitus	7.06e-05	0.000381	CcSEcCtD
Budesonide—Fatigue—Losartan—type 2 diabetes mellitus	7.04e-05	0.00038	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—TGFB1—type 2 diabetes mellitus	7.01e-05	0.00165	CbGpPWpGaD
Budesonide—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7e-05	0.000378	CcSEcCtD
Budesonide—Vomiting—Gliclazide—type 2 diabetes mellitus	6.98e-05	0.000377	CcSEcCtD
Budesonide—Constipation—Losartan—type 2 diabetes mellitus	6.98e-05	0.000377	CcSEcCtD
Budesonide—Pain—Losartan—type 2 diabetes mellitus	6.98e-05	0.000377	CcSEcCtD
Budesonide—Rash—Gliclazide—type 2 diabetes mellitus	6.93e-05	0.000374	CcSEcCtD
Budesonide—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.92e-05	0.000373	CcSEcCtD
Budesonide—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.9e-05	0.000373	CcSEcCtD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	6.89e-05	0.00162	CbGpPWpGaD
Budesonide—Urticaria—Irbesartan—type 2 diabetes mellitus	6.89e-05	0.000372	CcSEcCtD
Budesonide—Shock—Ramipril—type 2 diabetes mellitus	6.89e-05	0.000371	CcSEcCtD
Budesonide—Headache—Gliclazide—type 2 diabetes mellitus	6.88e-05	0.000371	CcSEcCtD
Budesonide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	6.86e-05	0.00037	CcSEcCtD
Budesonide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.86e-05	0.00037	CcSEcCtD
Budesonide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.86e-05	0.00037	CcSEcCtD
Budesonide—Tachycardia—Ramipril—type 2 diabetes mellitus	6.83e-05	0.000369	CcSEcCtD
Budesonide—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.82e-05	0.000368	CcSEcCtD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	6.82e-05	0.0016	CbGpPWpGaD
Budesonide—Skin disorder—Ramipril—type 2 diabetes mellitus	6.8e-05	0.000367	CcSEcCtD
Budesonide—Alclometasone—CYP3A4—type 2 diabetes mellitus	6.79e-05	0.0128	CrCbGaD
Budesonide—NR3C1—Adipogenesis—SERPINE1—type 2 diabetes mellitus	6.77e-05	0.00159	CbGpPWpGaD
Budesonide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.77e-05	0.000365	CcSEcCtD
Budesonide—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.73e-05	0.000363	CcSEcCtD
Budesonide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.67e-05	0.00036	CcSEcCtD
Budesonide—Dizziness—Valsartan—type 2 diabetes mellitus	6.67e-05	0.00036	CcSEcCtD
Budesonide—Anorexia—Ramipril—type 2 diabetes mellitus	6.67e-05	0.00036	CcSEcCtD
Budesonide—Flunisolide—CYP3A4—type 2 diabetes mellitus	6.62e-05	0.0125	CrCbGaD
Budesonide—Dizziness—Orlistat—type 2 diabetes mellitus	6.59e-05	0.000356	CcSEcCtD
Budesonide—Asthenia—Metformin—type 2 diabetes mellitus	6.59e-05	0.000356	CcSEcCtD
Budesonide—Paramethasone—CYP3A4—type 2 diabetes mellitus	6.53e-05	0.0123	CrCbGaD
Budesonide—Nausea—Gliclazide—type 2 diabetes mellitus	6.52e-05	0.000352	CcSEcCtD
Budesonide—Pruritus—Metformin—type 2 diabetes mellitus	6.5e-05	0.000351	CcSEcCtD
Budesonide—Urticaria—Losartan—type 2 diabetes mellitus	6.48e-05	0.00035	CcSEcCtD
Budesonide—Body temperature increased—Losartan—type 2 diabetes mellitus	6.45e-05	0.000348	CcSEcCtD
Budesonide—Abdominal pain—Losartan—type 2 diabetes mellitus	6.45e-05	0.000348	CcSEcCtD
Budesonide—Ciclesonide—CYP3A4—type 2 diabetes mellitus	6.43e-05	0.0121	CrCbGaD
Budesonide—Vomiting—Valsartan—type 2 diabetes mellitus	6.42e-05	0.000346	CcSEcCtD
Budesonide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.39e-05	0.000345	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000344	CcSEcCtD
Budesonide—Fluorometholone—CYP3A4—type 2 diabetes mellitus	6.38e-05	0.012	CrCbGaD
Budesonide—Rash—Valsartan—type 2 diabetes mellitus	6.36e-05	0.000343	CcSEcCtD
Budesonide—Dermatitis—Valsartan—type 2 diabetes mellitus	6.36e-05	0.000343	CcSEcCtD
Budesonide—Vomiting—Orlistat—type 2 diabetes mellitus	6.34e-05	0.000342	CcSEcCtD
Budesonide—Insomnia—Ramipril—type 2 diabetes mellitus	6.33e-05	0.000342	CcSEcCtD
Budesonide—Headache—Valsartan—type 2 diabetes mellitus	6.32e-05	0.000341	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	6.32e-05	0.00149	CbGpPWpGaD
Budesonide—Diarrhoea—Metformin—type 2 diabetes mellitus	6.29e-05	0.000339	CcSEcCtD
Budesonide—Rash—Orlistat—type 2 diabetes mellitus	6.29e-05	0.000339	CcSEcCtD
Budesonide—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000339	CcSEcCtD
Budesonide—Dermatitis—Orlistat—type 2 diabetes mellitus	6.28e-05	0.000339	CcSEcCtD
Budesonide—Headache—Orlistat—type 2 diabetes mellitus	6.25e-05	0.000337	CcSEcCtD
Budesonide—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.24e-05	0.000337	CcSEcCtD
Budesonide—Asthenia—Irbesartan—type 2 diabetes mellitus	6.22e-05	0.000336	CcSEcCtD
Budesonide—Somnolence—Ramipril—type 2 diabetes mellitus	6.22e-05	0.000336	CcSEcCtD
Budesonide—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	6.16e-05	0.0116	CrCbGaD
Budesonide—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.16e-05	0.000332	CcSEcCtD
Budesonide—Pruritus—Irbesartan—type 2 diabetes mellitus	6.14e-05	0.000331	CcSEcCtD
Budesonide—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000328	CcSEcCtD
Budesonide—Dizziness—Metformin—type 2 diabetes mellitus	6.08e-05	0.000328	CcSEcCtD
Budesonide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.04e-05	0.000326	CcSEcCtD
Budesonide—Fatigue—Ramipril—type 2 diabetes mellitus	6.03e-05	0.000326	CcSEcCtD
Budesonide—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.01e-05	0.000324	CcSEcCtD
Budesonide—Nausea—Valsartan—type 2 diabetes mellitus	5.99e-05	0.000323	CcSEcCtD
Budesonide—Constipation—Ramipril—type 2 diabetes mellitus	5.98e-05	0.000323	CcSEcCtD
Budesonide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.93e-05	0.00032	CcSEcCtD
Budesonide—Nausea—Orlistat—type 2 diabetes mellitus	5.92e-05	0.00032	CcSEcCtD
Budesonide—Asthenia—Losartan—type 2 diabetes mellitus	5.86e-05	0.000316	CcSEcCtD
Budesonide—Vomiting—Metformin—type 2 diabetes mellitus	5.84e-05	0.000315	CcSEcCtD
Budesonide—Rash—Metformin—type 2 diabetes mellitus	5.79e-05	0.000313	CcSEcCtD
Budesonide—Dermatitis—Metformin—type 2 diabetes mellitus	5.79e-05	0.000312	CcSEcCtD
Budesonide—Pruritus—Losartan—type 2 diabetes mellitus	5.77e-05	0.000312	CcSEcCtD
Budesonide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000311	CcSEcCtD
Budesonide—Headache—Metformin—type 2 diabetes mellitus	5.76e-05	0.000311	CcSEcCtD
Budesonide—Dizziness—Irbesartan—type 2 diabetes mellitus	5.74e-05	0.000309	CcSEcCtD
Budesonide—Hydrocortisone—NR3C1—type 2 diabetes mellitus	5.73e-05	0.0108	CrCbGaD
Budesonide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.72e-05	0.000309	CcSEcCtD
Budesonide—Dexamethasone—ABCC2—type 2 diabetes mellitus	5.6e-05	0.0106	CrCbGaD
Budesonide—Diarrhoea—Losartan—type 2 diabetes mellitus	5.58e-05	0.000301	CcSEcCtD
Budesonide—Urticaria—Ramipril—type 2 diabetes mellitus	5.56e-05	0.0003	CcSEcCtD
Budesonide—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.53e-05	0.000298	CcSEcCtD
Budesonide—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.53e-05	0.000298	CcSEcCtD
Budesonide—Vomiting—Irbesartan—type 2 diabetes mellitus	5.51e-05	0.000298	CcSEcCtD
Budesonide—Rash—Irbesartan—type 2 diabetes mellitus	5.47e-05	0.000295	CcSEcCtD
Budesonide—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.46e-05	0.000295	CcSEcCtD
Budesonide—Nausea—Metformin—type 2 diabetes mellitus	5.46e-05	0.000295	CcSEcCtD
Budesonide—Headache—Irbesartan—type 2 diabetes mellitus	5.43e-05	0.000293	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	5.42e-05	0.00127	CbGpPWpGaD
Budesonide—Dizziness—Losartan—type 2 diabetes mellitus	5.4e-05	0.000291	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	5.29e-05	0.00124	CbGpPWpGaD
Budesonide—Triamcinolone—CYP3A4—type 2 diabetes mellitus	5.2e-05	0.0098	CrCbGaD
Budesonide—Vomiting—Losartan—type 2 diabetes mellitus	5.19e-05	0.00028	CcSEcCtD
Budesonide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000278	CcSEcCtD
Budesonide—Nausea—Irbesartan—type 2 diabetes mellitus	5.15e-05	0.000278	CcSEcCtD
Budesonide—Rash—Losartan—type 2 diabetes mellitus	5.15e-05	0.000278	CcSEcCtD
Budesonide—Dermatitis—Losartan—type 2 diabetes mellitus	5.14e-05	0.000277	CcSEcCtD
Budesonide—Headache—Losartan—type 2 diabetes mellitus	5.11e-05	0.000276	CcSEcCtD
Budesonide—Triamcinolone—PTGS2—type 2 diabetes mellitus	5.09e-05	0.00959	CrCbGaD
Budesonide—Asthenia—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000271	CcSEcCtD
Budesonide—Pruritus—Ramipril—type 2 diabetes mellitus	4.95e-05	0.000267	CcSEcCtD
Budesonide—Nausea—Losartan—type 2 diabetes mellitus	4.85e-05	0.000262	CcSEcCtD
Budesonide—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.79e-05	0.000258	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	4.74e-05	0.00112	CbGpPWpGaD
Budesonide—Prednisone—CYP3A4—type 2 diabetes mellitus	4.71e-05	0.00888	CrCbGaD
Budesonide—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	4.7e-05	0.0011	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	4.66e-05	0.00109	CbGpPWpGaD
Budesonide—Dizziness—Ramipril—type 2 diabetes mellitus	4.63e-05	0.00025	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	4.58e-05	0.00108	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	4.47e-05	0.00105	CbGpPWpGaD
Budesonide—Vomiting—Ramipril—type 2 diabetes mellitus	4.45e-05	0.00024	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	4.44e-05	0.00104	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	4.44e-05	0.00104	CbGpPWpGaD
Budesonide—Rash—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000238	CcSEcCtD
Budesonide—Dermatitis—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000238	CcSEcCtD
Budesonide—Headache—Ramipril—type 2 diabetes mellitus	4.38e-05	0.000237	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	4.38e-05	0.00103	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	4.37e-05	0.00103	CbGpPWpGaD
Budesonide—Prednisolone—CYP3A4—type 2 diabetes mellitus	4.35e-05	0.00819	CrCbGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	4.34e-05	0.00102	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	4.3e-05	0.00101	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	4.27e-05	0.001	CbGpPWpGaD
Budesonide—Dexamethasone—NR3C1—type 2 diabetes mellitus	4.27e-05	0.00805	CrCbGaD
Budesonide—Betamethasone—CYP3A4—type 2 diabetes mellitus	4.26e-05	0.00802	CrCbGaD
Budesonide—Betamethasone—PTGS2—type 2 diabetes mellitus	4.17e-05	0.00786	CrCbGaD
Budesonide—Nausea—Ramipril—type 2 diabetes mellitus	4.16e-05	0.000224	CcSEcCtD
Budesonide—Prednisone—ALB—type 2 diabetes mellitus	4.11e-05	0.00775	CrCbGaD
Budesonide—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	4.04e-05	0.000949	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	4.03e-05	0.000946	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	3.99e-05	0.000938	CbGpPWpGaD
Budesonide—Dexamethasone—CYP2E1—type 2 diabetes mellitus	3.93e-05	0.00741	CrCbGaD
Budesonide—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3.66e-05	0.000861	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	3.62e-05	0.000851	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	3.61e-05	0.000849	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	3.57e-05	0.000839	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	3.45e-05	0.000811	CbGpPWpGaD
Budesonide—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	3.32e-05	0.00626	CrCbGaD
Budesonide—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	3.32e-05	0.000781	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	3.22e-05	0.000757	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	3.04e-05	0.000715	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	2.78e-05	0.000654	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.77e-05	0.000652	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	2.74e-05	0.000645	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.74e-05	0.000643	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	2.66e-05	0.000625	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	2.66e-05	0.000625	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	2.61e-05	0.000614	CbGpPWpGaD
Budesonide—Dexamethasone—CYP3A4—type 2 diabetes mellitus	2.48e-05	0.00467	CrCbGaD
Budesonide—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	2.47e-05	0.000581	CbGpPWpGaD
Budesonide—Dexamethasone—PTGS2—type 2 diabetes mellitus	2.42e-05	0.00457	CrCbGaD
Budesonide—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	2.26e-05	0.000532	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	2.12e-05	0.000498	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	2.11e-05	0.000496	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.94e-05	0.000457	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	1.92e-05	0.000452	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.85e-05	0.000435	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.85e-05	0.000435	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.75e-05	0.000412	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.75e-05	0.000412	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.7e-05	0.000399	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.67e-05	0.000393	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	1.6e-05	0.000376	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.54e-05	0.000363	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.54e-05	0.000363	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.49e-05	0.000351	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.49e-05	0.000351	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.49e-05	0.000351	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.49e-05	0.000351	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.49e-05	0.000351	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.44e-05	0.000339	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.36e-05	0.000321	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.36e-05	0.000321	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.33e-05	0.000312	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	1.32e-05	0.000311	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.27e-05	0.000298	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.27e-05	0.000298	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.27e-05	0.000298	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.22e-05	0.000286	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.22e-05	0.000286	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.19e-05	0.00028	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.17e-05	0.000275	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.17e-05	0.000275	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.15e-05	0.00027	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.13e-05	0.000266	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.13e-05	0.000266	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.13e-05	0.000266	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.06e-05	0.00025	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	9.95e-06	0.000234	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	9.61e-06	0.000226	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	9.61e-06	0.000226	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	9.61e-06	0.000226	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	9.61e-06	0.000226	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	9.21e-06	0.000217	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	8.56e-06	0.000201	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	7.99e-06	0.000188	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	7.83e-06	0.000184	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	7.83e-06	0.000184	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7.68e-06	0.000181	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	7.63e-06	0.000179	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	7.63e-06	0.000179	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	7.63e-06	0.000179	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	7.59e-06	0.000178	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	7.45e-06	0.000175	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	7.36e-06	0.000173	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.85e-06	0.000161	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.85e-06	0.000161	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.85e-06	0.000161	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.72e-06	0.000158	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.66e-06	0.000157	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	6.52e-06	0.000153	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	6.26e-06	0.000147	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	6.19e-06	0.000146	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	6.19e-06	0.000146	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.94e-06	0.00014	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.94e-06	0.00014	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	5.22e-06	0.000123	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.12e-06	0.00012	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.12e-06	0.00012	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.09e-06	0.00012	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.03e-06	0.000118	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.88e-06	0.000115	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.75e-06	0.000112	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.66e-06	0.000109	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.56e-06	0.000107	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.54e-06	0.000107	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.43e-06	0.000104	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.37e-06	0.000103	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.19e-06	9.86e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.11e-06	9.67e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.98e-06	9.37e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.92e-06	9.21e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.9e-06	9.18e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.86e-06	9.07e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.4e-06	7.99e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.34e-06	7.84e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.06e-06	7.19e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.93e-06	6.88e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.93e-06	6.88e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.68e-06	6.29e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.34e-06	3.16e-05	CbGpPWpGaD
